IFNA1 and neoplasm: Here we exploited a novel, immune-competent mouse model mimicking human B-ALL14 and show that monocyte-mediated IFNα delivery can reprogram the TME towards inducing effective anti-tumor immune responses and synergizes with checkpoint blockade and adoptive T-cell immunotherapies in the treatment of a disseminated hematologic malignancy.